(Q50867875)

24 March 2018

title

Reduced level of plasma antioxidant uric acid in schizophrenia. (English)

1 reference

24 March 2018

0 references

Yao JK

1

1 reference

24 March 2018

Reddy R

series ordinal

2

1 reference

24 March 2018

van Kammen DP

series ordinal

3

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

24 March 2018

published in

Psychiatry Research

1 reference

24 March 2018

volume

80

1 reference

24 March 2018

issue

1

1 reference

24 March 2018

page(s)

29-39

1 reference

24 March 2018

Negative symptoms in schizophrenia. Definition and reliability

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Towards the physiological function of uric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Methods for reliable longitudinal observation of behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Blood cotinine levels as indicators of smoking treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Comparison of tests used to distinguish smokers from nonsmokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Determinants of antioxidant status in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Increased pentane and carbon disulfide in the breath of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Free radical pathology in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Serum urate as an antioxidant for ascorbic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Reduced status of plasma total antioxidant capacity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Decreased serotonergic responsivity in platelets of drug-free patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2898%2900051-1

7 January 2021

10.1016/S0165-1781(98)00051-1

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018